Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo

NCT06109649 is registered in ClinicalTrials.gov with Clinuvel, Inc. as lead sponsor.

NCT NCT06109649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06109649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet B (NB-UVB) Light Versus NB-UVB Light Alone in the Treatment of Vitiligo
Lead sponsor
Clinuvel, Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 11, 2023
Completion date
June 30, 2026
Enrollment
200 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo